Trial intelligence / Profile preview

Dexmedetomidine versus lidocaine for suppression of cough after anesthesia

IRCT20141209020258N97Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Sep 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in cough comparing Dexmedetomidine, Lidocaine and Placebo (3 arms). Primary endpoints: cough, laryngospasm and 4 more. Started Sep 2018; status: completed.

02

Drugs

dexmedetomidinelidocaine
03

Conditions

cough

Beyond the preview

Go deeper on IRCT20141209020258N97.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20141209020258N97.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call